학술논문
P.3.d.018 Phase 2 clinical trial of TC-5619, an alpha 7 nicotinic receptor agonist in the treatment of negative and cognitive symptoms in schizophrenia
Document Type
Abstract
Author
Source
In European Neuropsychopharmacology October 2014 24 Supplement 2:S531-S532
Subject
Language
ISSN
0924-977X